Cargando…
EGFR基因多态性对EGFR-TKIs治疗晚期NSCLC疗效和预后的影响
An increasing number of patients with advanced non-small cell lung cancer (NSCLC) have been treated with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). However, significant differences in response to EGFR-TKIs have been shown among advanced NSCLC patients. Recently, selecti...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015131/ https://www.ncbi.nlm.nih.gov/pubmed/23514947 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.03.09 |